- Prognostic significance of programmed cell death-ligand 1 expression on immune cells and epithelialmesenchymal transition expression in patients with hepatocellular carcinoma
-
Jung HI, Ahn H, Oh MH, Yun J, Lee H, Bae SH, Kim YK, Kim SY, Baek MJ, Lee MS
- KMID: 2547535
- Ann Surg Treat Res.
- 2023 Nov;105(5):297-309.
- doi: 10.4174/astr.2023.105.5.297
Purpose: Immune checkpoint inhibitors (ICIs) have been shown significant oncological improvements in several cancers. However, ICIs are still in their infancy in hepatocellular carcinoma (HCC). Programmed cell death-ligand 1 (PD-L1), tumorinfiltrating... -
- CITED
-
- Close
- SHARE
-
- Close
- The Effect of Model for End-Stage Liver Disease 3.0 on Disparities between Patients with and without Hepatocellular Carcinoma in Korea
-
Kim K, Kim DG, Lee JG, Joo DJ, Lee HW
- KMID: 2547182
- Yonsei Med J.
- 2023 Nov;64(11):647-657.
- doi: 10.3349/ymj.2023.0163
Purpose: The model for end-stage liver disease (MELD) 3.0 has recently been suggested for determining liver allocation. We aimed to apply MELD 3.0 to a Korean population and to discover... -
- CITED
-
- Close
- SHARE
-
- Close
- Long Noncoding RNA Cytoskeleton Regulator RNA Suppresses Apoptosis in Hepatoma Cells by Modulating the miR-125a-5p/ HS1-Associated Protein X-1 Axis to Induce Caspase-9 Inactivation
-
Wu ZY, Wang Y, Hu H, Ai XN, Zhang Q, Qin YG
- KMID: 2548450
- Gut Liver.
- 2023 Nov;17(6):916-925.
- doi: 10.5009/gnl210572
Background/Aims: The involvement of long noncoding RNAs in the carcinogenesis of hepatocellular carcinoma (HCC) has been well documented by substantial evidence. However, whether cytoskeleton regulator RNA (CYTOR) could affect the... -
- CITED
-
- Close
- SHARE
-
- Close
- Drug-Eluting Bead Transarterial Chemoembolization Versus Radiofrequency Ablation as an Initial Treatment of Single Small (≤ 3 cm) Hepatocellular Carcinoma
-
Lee S, Jeong YY, Lee BC, Shin SS, Heo SH, Kim HO, Park C, Jeong WG
- KMID: 2547563
- J Korean Med Sci.
- 2023 Oct;38(42):e362.
- doi: 10.3346/jkms.2023.38.e362
Background: In this study, we aimed to compare the long-term therapeutic outcomes of drug-eluting bead transarterial chemoembolization (DEB-TACE) with those of radiofrequency ablation (RFA) for the initial treatment of a... -
- CITED
-
- Close
- SHARE
-
- Close
- Novel paradigm in the treatment of hepatocellular carcinoma: Anticipating breakthroughs with particle therapy
-
Yoon SM
- KMID: 2546383
- Clin Mol Hepatol.
- 2023 Oct;29(4):977-979.
- doi: 10.3350/cmh.2023.0336
-
- CITED
-
- Close
- SHARE
-
- Close
- Utility of fusion imaging for the evaluation of ultrasound quality in hepatocellular carcinoma surveillance
-
Kim YY, Cho SB, Lee JS, Lee HW, Choi JY, Kim SU
- KMID: 2546456
- Ultrasonography.
- 2023 Oct;42(4):580-588.
- doi: 10.14366/usg.23106
Purpose: This study evaluated the quality of surveillance ultrasound (US) for hepatocellular carcinoma (HCC) utilizing fusion imaging. Methods: This research involved a secondary analysis of a prospectively recruited cohort. Under institutional... -
- CITED
-
- Close
- SHARE
-
- Close
- Chemoembolization combined with radiofrequency ablation is the best option for the local treatment of early hepatocellular carcinoma?
-
Kim HC
- KMID: 2546385
- Clin Mol Hepatol.
- 2023 Oct;29(4):984-986.
- doi: 10.3350/cmh.2023.0275
-
- CITED
-
- Close
- SHARE
-
- Close
- Carbon Ion Radiotherapy in the Treatment of Hepatocellular Carcinoma
-
Byun HK, Kim C, Seong J
- KMID: 2546379
- Clin Mol Hepatol.
- 2023 Oct;29(4):945-957.
- doi: 10.3350/cmh.2023.0217
Hepatocellular carcinoma (HCC) is a highly lethal cancer with limited treatment options and poor prognosis. Carbon ion radiotherapy (CIRT) has emerged as a promising treatment modality for HCC due to... -
- CITED
-
- Close
- SHARE
-
- Close
- Loco-regional therapies competing with radiofrequency ablation in potential indications for hepatocellular carcinoma: a network meta-analysis
-
Kim HI, An J, Han S, Shim JH
- KMID: 2546388
- Clin Mol Hepatol.
- 2023 Oct;29(4):1013-1028.
- doi: 10.3350/cmh.2023.0131
Background/Aims: There is no clear consensus on the relative ranking of interventional and radiation techniques with indications similar to those of radiofrequency ablation (RFA) for the treatment of early hepatocellular... -
- CITED
-
- Close
- SHARE
-
- Close
- Sonazoid-enhanced ultrasonography for noninvasive imaging diagnosis of hepatocellular carcinoma: special emphasis on the 2022 KLCA-NCC guideline
-
Kang HJ, Lee JM, Kim SW
- KMID: 2546447
- Ultrasonography.
- 2023 Oct;42(4):479-489.
- doi: 10.14366/usg.23051
Contrast-enhanced ultrasonography (CEUS) is a noninvasive imaging modality used to diagnose hepatocellular carcinoma (HCC) based on specific imaging features, without the need for pathologic confirmation. Two types of ultrasound contrast... -
- CITED
-
- Close
- SHARE
-
- Close
- The evolving role of lenvatinib at the new era of first-line hepatocellular carcinoma treatment
-
Chan LL, Chan SL
- KMID: 2546377
- Clin Mol Hepatol.
- 2023 Oct;29(4):909-923.
- doi: 10.3350/cmh.2023.0114
Emergence of multi-targeted kinase inhibitors (MTIs) and immune checkpoint inhibitors (ICI) have changed the landscape of management in hepatocellular carcinoma (HCC). Combination therapy involving ICI has superseded sorafenib as the... -
- CITED
-
- Close
- SHARE
-
- Close
- Bilateral Ovarian Metastases of Hepatocellular Carcinoma Diagnosed with 18F‑Fluorocholine PET/CT in a Patient with Endometriosis
-
Latgé A, Averous G, Gressel A, Faitot F, Leroy‑Freschini B
- KMID: 2547015
- Nucl Med Mol Imaging.
- 2023 Oct;57(5):251-253.
- doi: 10.1007/s13139-023-00796-4
A 47-year-old woman with history of hepatocellular carcinoma was referred for 18F-fluorocholine PET/CT evaluation due to elevated alpha-fetoprotein. The examination showed several peritoneal uptakes and two nodular pelvic foci. Coelioscopic... -
- CITED
-
- Close
- SHARE
-
- Close
- Laparoscopic right posterior sectionectomy for a large hepatocellular carcinoma close to inferior vena cava
-
Anand S, Jayapal L, Ema SST, Jameel JKA, Reddy PK
- KMID: 2546183
- J Minim Invasive Surg.
- 2023 Sep;26(3):162-165.
- doi: 10.7602/jmis.2023.26.3.162
Approximately 20% of hepatocellular carcinomas (HCC) occur in noncirrhotic livers. Resection may be considered for patients with HCC, provided sufficient future liver remnant is available, regardless of the tumor size.... -
- CITED
-
- Close
- SHARE
-
- Close
- Donor sex and donor-recipient sex disparity do not affect hepatocellular carcinoma recurrence after living donor liver transplantation
-
Oh RK, Hwang S, Song GW, Ahn CS, Moon DB, Ha TY, Jung DH, Park GC, Yoon YI, Kang WH
- KMID: 2545904
- Ann Surg Treat Res.
- 2023 Sep;105(3):133-140.
- doi: 10.4174/astr.2023.105.3.133
Purpose: Studies have yielded contradictory results on whether donor sex and donor-recipient sex disparity affect hepatocellular carcinoma (HCC) recurrence after living donor liver transplantation (LDLT). The present study assessed whether... -
- CITED
-
- Close
- SHARE
-
- Close
- Treatment Outcomes of Percutaneous Radiofrequency Ablation for Hepatocellular Carcinomas: Effects of the Electrode Type and Placement Method
-
Park J, Lee MW, Ahn SH, Han S, Min JH, Cha DI, Song KD, Kang TW, Rhim H
- KMID: 2544929
- Korean J Radiol.
- 2023 Aug;24(8):761-771.
- doi: 10.3348/kjr.2023.0022
Objective: To investigate the association among the electrode placement method, electrode type, and local tumor progression (LTP) following percutaneous radiofrequency ablation (RFA) for small hepatocellular carcinomas (HCCs) and to assess... -
- CITED
-
- Close
- SHARE
-
- Close
- No-Touch Radiofrequency Ablation for Early Hepatocellular Carcinoma: 2023 Korean Society of Image-Guided Tumor Ablation Guidelines
-
Han S, Lee MW, Lee YJ, Hong HP, Lee DH, Lee JM
- KMID: 2544925
- Korean J Radiol.
- 2023 Aug;24(8):719-728.
- doi: 10.3348/kjr.2023.0423
Radiofrequency ablation (RFA) has been widely used to manage hepatocellular carcinomas (HCCs) equal to or smaller than 3 cm. No-touch RFA has gained attention and has recently been implemented in... -
- CITED
-
- Close
- SHARE
-
- Close
- A Case of Transverse Myelitis Following Treatment with Atezolizumab for Advanced Hepatocellular Carcinoma
-
Kim KH, Baek YH, Kang YW, Yoon BA, Moon SY
- KMID: 2544938
- Korean J Gastroenterol.
- 2023 Jul;82(1):35-39.
- doi: 10.4166/kjg.2023.054
The results of the IMbrave150 study have led to widespread use of the combination therapy of atezolizumab and bevacizumab as a first-line treatment for unresectable or metastatic hepatocellular carcinoma (HCC).... -
- CITED
-
- Close
- SHARE
-
- Close
- Recurrence in patients with totally necrotic nodules of hepatocellular carcinoma after liver transplantation: “totally” an inaccurate description
-
Kim J, Hong SK, Kim JY, Lee J, Choi HH, Lee S, Hong Sy, Lee JM, Choi Y, Yi NJ, Lee KW, Suh KS
- KMID: 2544612
- Ann Surg Treat Res.
- 2023 Jul;105(1):47-56.
- doi: 10.4174/astr.2023.105.1.47
Purpose: Total necrosis of hepatocellular carcinoma (HCC) achieved via locoregional treatment (LRT) is considered to indicate a lack of tumor viability. Nonetheless, there is insufficient evidence of recurrence after liver... -
- CITED
-
- Close
- SHARE
-
- Close
- Circ-SNX27 sponging miR-375/RPN1 axis contributes to hepatocellular carcinoma progression
-
Zheng C, Liang J, Yu S, Xu H, Dai L, Xu D
- KMID: 2544135
- Korean J Physiol Pharmacol.
- 2023 Jul;27(4):333-344.
- doi: 10.4196/kjpp.2023.27.4.333
Hepatocellular carcinoma (HCC) is a prevalent malignant tumor with high fatality. It has yet to be reported whether circ-SNX27 can affect the progression of HCC. This study attempted to analyze... -
- CITED
-
- Close
- SHARE
-
- Close
- Transarterial chemoembolization for hepatocellular carcinoma: 2023 Expert consensus-based practical recommendations of the Korean Liver Cancer Association
-
Cho Y, Choi JW, Kwon H, Kim KY, Lee BC, Chu HH, Lee DH, Lee HA, Kim GM, Oh JS, Hyun D, Lee IJ, Rhim H, Research Committee of the Korean Liver Cancer Association
- KMID: 2543980
- Clin Mol Hepatol.
- 2023 Jul;29(3):521-541.
- doi: 10.3350/cmh.2023.0202
Transarterial chemoembolization (TACE) was introduced in 1977 with the administration of chemotherapeutic agent to gelatin sponge particles through the hepatic artery in patients with hepatocellular carcinoma (HCC) and was established... -
- CITED
-
- Close
- SHARE
-
- Close
